Ironwood Pharmaceuticals | IRWD - Interest Income



Ironwood Pharmaceuticals reported $778K in Interest Income for its fiscal quarter ending in December of 2024.


Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Almirall 2M 1.44M Mar/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Amarin USD 3.37M 3.37M Dec/2024
Astellas Pharma 4.12B 2.94B Mar/2024
AstraZeneca 68M 16M Jun/2025
Charles River Laboratories USD 1.1M 307K Jun/2025
Exact Sciences -5.29 5.08 Dec/2024
Incyte 25.14M 2.21M Jun/2025
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
MacroGenics 1.41M 1.41M Jun/2025
Moderna USD 81M 9M Jun/2025
Myriad Genetics USD 300K 0 Mar/2025
Pacira USD 5.01M 1.89M Jun/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Takeda 73.76B 81.93B Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025